The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic

• Príomhchruthaitheoirí: Aref Shariati (Údar), Maniya Arshadi (Údar), Mohammad Ali Khosrojerdi (Údar), Mostafa Abedinzadeh (Údar), Mahsa Ganjalishahi (Údar), Abbas Maleki (Údar), Mohsen Heidary (Údar), Saeed Khoshnood (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Frontiers Media S.A., 2022-12-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

For around three decades, the fluoroquinolone (FQ) antibiotic ciprofloxacin has been used to treat a range of diseases, including chronic otorrhea, endocarditis, lower respiratory tract, gastrointestinal, skin and soft tissue, and urinary tract infections. Ciprofloxacin's main mode of action is...